NOVARTIS AG (NVSEF)
Clinical trial NCT06941792 updates: 1. completion date: 2026-01-30 → 2027-04-30 2. primary completion date: 2026-01-30 → 2027-04-30 3. enrollment: not set → 1590 participants
Clinical trial NCT06941792 updates: 1. completion date: 2026-01-30 → 2027-04-30 2. primary completion date: 2026-01-30 → 2027-04-30 3. enrollment: not set → 1590 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical